Abstract
A potential anticancer heterodinuclear ruthenium(II)ââ"šÂ¬Ã¢â‚¬Å“platinum(II) complex, [ruthenium(II)(4,4ââ"šÂ¬Ã‚²-dimethyl-2,2ââ"šÂ¬Ã‚²-bipyridine)2(5-(l-cysteine-methyl ester)-1,10-phenanthroline)-trans-chlorodiammineplatinum(II)] chloride, [Ru(Me2bipy)2(5-(l-cysteine-Me)-phen)-trans-Pt(NH3)2Cl]Cl3, was synthesised. l-Cysteine methyl ester was used to link the two metal centres, as more conventional straight chain diaminoalkanes and 2-mercaptoethylamine failed to couple to the phenanthroline ligand. From the precursor mononuclear ruthenium(II) complexes, which were separated into their ÃŽâ€Â- and Λ-isomers by column chromatography, the dinuclear complex was synthesised and characterised by 1H and 13C NMR, UVââ"šÂ¬Ã¢â‚¬Å“Vis, circular dichroism, fluorescence and electrospray ionisation mass spectrometry.
| Original language | English |
|---|---|
| Number of pages | 11 |
| Journal | Polyhedron |
| Publication status | Published - 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- anticancer
- heterodinuclear
- l-Cysteine methyl ester
- phenanthroline
- platinum(II)
- ruthenium(II)
Fingerprint
Dive into the research topics of 'Synthesis of a heterodinuclear ruthenium(II)-platinum(II) complex linked by L-cysteine methyl ester'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver